Michael Schmertzler is of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 123,266 shares of PTCT, which is worth approximately $4.92 Million. The most recent transaction as insider was on Feb 15, 2024, when has been sold 8,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K
0% 3M change
5.57% 12M change
Total Value Held $4.92 Million

MICHAEL SCHMERTZLER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2024
BUY
Grant, award, or other acquisition
-
8,000 Added 6.09%
123,266 Common Stock
Jan 08 2024
SELL
Open market or private sale
$41,715 $27.81 p/Share
1,500 Reduced 1.28%
115,266 Common Stock
Jun 07 2023
SELL
Open market or private sale
$44,860 $44.86 p/Share
1,000 Reduced 0.85%
116,766 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
8,000 Added 6.36%
117,766 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
6,400 Added 5.51%
109,766 Common Stock
Jan 06 2021
BUY
Grant, award, or other acquisition
-
3,300 Added 3.09%
103,366 Common Stock

Also insider at

HLNE
Hamilton Lane INC Financial Services
MS

Michael Schmertzler

St. Petersburg, FL

Track Institutional and Insider Activities on PTCT

Follow PTC THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT